Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel in Metastatic Pancreatic Adenocarcinoma

NCT04115163 is registered in ClinicalTrials.gov with Anne Noonan as lead sponsor.

NCT NCT04115163
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04115163 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel in Metastatic Pancreatic Adenocarcinoma
Lead sponsor
Anne Noonan
Phase
Phase 2
Overall status
Active, not recruiting
Start date
June 24, 2020
Completion date
December 31, 2026
Enrollment
67 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic pancreatic adenocarcinoma, stage iv pancreatic cancer ajcc v8